Table 5.
Short-Form Health Survey-12 (Mental and Physical) outcome analysis with imputed data (N=221): intervention comparisons along the follow-up.
| Secondary outcomes | Time 1 (pretreatment) | Time 2 (posttreatment) | Time 3 (6 months) | Time 4 (12 months) | |||||
| Mental Scale SF-12a | |||||||||
|
|
iTAUb vs HLPc | ||||||||
|
|
|
gd | –0.06 | –0.42 | –0.11 | 0.01 | |||
|
|
|
P value | .73 | .02e | .53 | .98 | |||
|
|
|
βf (95% CI) | –0.63 (–4.25 to 2.99) | –5.32 (–9.91 to –0.72) | –1.53 (–6.30 to 3.23) | –0.05 (–5.04 to 4.93) | |||
|
|
iTAU vs MPg | ||||||||
|
|
|
g | 0.14 | 0.16 | 0.01 | –0.05 | |||
|
|
|
P value | .46 | .38 | .94 | .81 | |||
|
|
|
β (95% CI) | –1.37 (–4.99 to 2.24) | –2.06 (–6.66 to 2.53) | –0.18 (–4.95 to 4.58) | 0.62 (–4.36 to 5.61) | |||
|
|
iTAU vs PAPPh | ||||||||
|
|
|
g | 0.15 | 0.67 | 0.22 | 0.24 | |||
|
|
|
P value | .45 | .001 | .28 | .20 | |||
|
|
|
β (95% CI) | –1.37 (–4.96 to 2.21) | –7.72 (–12.27 to –3.16) | –2.61 (–7.33 to 2.11) | –3.2 (–8.14 to 1.74) | |||
|
|
HLP vs MP | ||||||||
|
|
|
g | 0.07 | –0.25 | –0.1 | –0.05 | |||
|
|
|
P value | .69 | .17 | .58 | .79 | |||
|
|
|
β (95% CI) | –0.74 (–4.41 to 2.93) | 3.25 (–1.41 to 7.91) | 1.35 (–3.48 to 6.18) | 0.68 (–4.37 to 5.73) | |||
|
|
HLP vs PAPP | ||||||||
|
|
|
g | 0.01 | 0.17 | –0.07 | –0.12 | |||
|
|
|
P value | .97 | .38 | .72 | .49 | |||
|
|
|
β (95% CI) | –0.07 (–4.22 to 4.08) | –2.04 (–6.59 to 2.51) | 0.76 (–3.41 to 4.92) | 1.36 (–2.51 to 5.24) | |||
|
|
MP vs PAPP | ||||||||
|
|
|
g | 0.23 | 0.23 | 0.25 | 0.09 | |||
|
|
|
P value | .20 | .23 | .23 | .62 | |||
|
|
|
β (95% CI) | –2.72 (–6.87 to 1.43) | –2.77 (–7.32 to 1.78) | –2.53 (–6.69 to 1.64) | –0.97 (–4.85 to 2.9) | |||
| Physical Scale SF-12 | |||||||||
|
|
iTAU vs HLP | ||||||||
|
|
|
g | 0.04 | 0.37 | 0.39 | –0.19 | |||
|
|
|
P value | .86 | .047 | .03 | .35 | |||
|
|
|
β (95% CI) | 0.36 (–3.77 to 4.5) | 4.58 (0.05 to 9.11) | 4.73 (0.58 to 8.87) | –1.85 (–5.7 to 2.01) | |||
|
|
iTAU vs MP | ||||||||
|
|
|
g | –0.25 | –0.42 | –0.73 | –0.05 | |||
|
|
|
P value | .15 | .02 | .001 | .80 | |||
|
|
|
β (95% CI) | 3.01 (–1.12 to 7.14) | 5.32 (0.79 to 9.85) | 8.01 (3.87 to 12.16) | 0.49 (–3.37 to 4.35) | |||
|
|
iTAU vs PAPP | ||||||||
|
|
|
g | –0.03 | –0.21 | –0.50 | 0.05 | |||
|
|
|
P value | .89 | .27 | .009 | .80 | |||
|
|
|
β (95% CI) | 0.29 (–3.8 to 4.39) | 2.54 (–1.94 to 7.03) | 5.49 (1.38 to 9.6) | –0.48 (–4.3 to 3.34) | |||
|
|
HLP vs MP | ||||||||
|
|
|
g | –0.22 | –0.06 | –0.29 | –0.21 | |||
|
|
|
P value | .21 | .75 | .13 | .24 | |||
|
|
|
β (95% CI) | 2.65 (–1.54 to 6.83) | 0.73 (–3.86 to 5.32) | 3.28 (–0.92 to 7.49) | 2.34 (–1.57 to 6.25) | |||
|
|
HLP vs PAPP | ||||||||
|
|
|
g | 0.08 | 0.20 | 0.09 | 0.23 | |||
|
|
|
P value | .69 | .31 | .66 | .22 | |||
|
|
|
β (95% CI) | –0.74 (–4.37 to 2.9) | –2.4 (–7.02 to 2.22) | –1.08 (–5.86 to 3.71) | –3.15 (–8.15 to 1.86) | |||
|
|
MP vs PAPP | ||||||||
|
|
|
g | 0.01 | 0.47 | 0.20 | 0.28 | |||
|
|
|
P value | >.99 | .02 | .32 | .13 | |||
|
|
|
β (95% CI) | 0.01 (–3.63 to 3.64) | –5.65 (–10.27 to –1.03) | –2.43 (–7.21 to 2.36) | –3.82 (–8.83 to 1.18) | |||
aSF-12: 12-item Short-Form Health Survey.
biTAU: improved treatment as usual.
cHLP: healthy lifestyle program.
dg: Hedge’s effect size measure.
eStatistically significant values (P<.05) are shown in italics.
fβ: regression coefficient.
gMP: mindfulness program.
hPAPP: positive affect promotion program.